While U.S. label expansion efforts continue, CV Therapeutics Inc. granted ex-U.S. marketing rights for angina drug Ranexa (ranolazine prolonged-release tablets) to Menarini Group, of Florence, Italy. (BioWorld Today) Read More
Nanophotonics pioneer Naomi Halas is one of the most recognized researchers in the field of nanotechnology, best known for her invention of nanoshells, a new type of nanoparticle with tunable optical properties especially suited for biotechnology applications. Now her invention is bearing fruit via a company she and her nanoshell collaborator Jennifer West founded. Nanospectra Biosciences, of Houston, has commenced a pilot human trial of its AuroLase Therapy in refractory and/or recurrent head and neck cancers. Read More